The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
A Dose-Ranging Study of the Effects of Ethyl-Eicosapentaenoate in Patients With Ongoing Depression Despite Apparently Adequate Treatment With Standard Drugs
Abstract
BACKGROUND: In depressed patients, low blood levels of eicosapentaenoic acid are seen. We tested the antidepressive effect of ethyl-eicosapentaenoate in these patients. METHODS: We included 70 patients with persistant depression despite ongoing treatment with an adequate dose of a standard antidepressant. Patients were randomized on a double-blind basis to placebo or ethyl-eicosapentaenoate at dosages of 1, 2, or 4 g/d for 12 weeks in addition to unchanged background medication. Patients underwent assessment using the 17-item Hamilton Depression Rating Scale, the Montgomery-Asberg Depression Rating Scale, and the Beck Depression Inventory. RESULTS: Forty-six (88%) of 52 patients receiving ethyl-eicosapentaenoate and 14 (78%) of 18 patients receiving placebo completed the 12-week study with no serious adverse events. The 1-g/d group showed a significantly better outcome than the placebo group on all 3 rating scales. In the intention-to-treat group, 5 (29%) of 17 patients receiving placebo and 9 (53%) of 17 patients receiving 1 g/d of ethyl-eicosapentaenoate achieved a 50% reduction on the Hamilton Depression Rating Scale score. In the per-protocol group, the corresponding figures were 3 (25%) of 12 patients for placebo and 9 (69%) of 13 patients for the 1-g/d group. The 2-g/d group showed little evidence of efficacy, whereas the 4-g/d group showed nonsignificant trends toward improvement. All of the individual items on all 3 rating scales improved with the 1-g/d dosage of ethyl-eicosapentaenoate vs placebo, with strong beneficial effects on items rating depression, anxiety, sleep, lassitude, libido, and suicidality. CONCLUSION: Treatment with ethyl-eicosapentaenoate at a dosage of 1 g/d was effective in treating depression in patients who remained depressed despite adequate standard therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
(1999) · The Lancet · doi:10.1016/s0140-6736(99)07072-5 · Cited by 3,812 · cited 1×
“In 2 large trials, EPA-containing products (providing EPA at a dosage of less than 1 g/d) have been shown to reduce mortality related to heart disease.(36,37) In view of the steadily increasing evidence of associations between various types of cardiovascular disease and depression, and that both disorders are associat…”
BackgroundBurr, M. L., Gilbert, J. F., Holliday, R. M., Elwood, P. C., Fehily, A. M., Rogers, S., Sweetnam, P. M., & Deadman, N. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90828-3 · Cited by 2,610 · cited 1×
“In 2 large trials, EPA-containing products (providing EPA at a dosage of less than 1 g/d) have been shown to reduce mortality related to heart disease.(36,37) In view of the steadily increasing evidence of associations between various types of cardiovascular disease and depression, and that both disorders are associat…”
BackgroundAnderson, I. M. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00092-0 · Cited by 940
Fish consumption and major depression
Hibbeln, J. R. (1998) · The Lancet · doi:10.1016/s0140-6736(05)79168-6 · Cited by 896
Omega 3 Fatty Acids in Bipolar Disorder: A Preliminary Double-blind, Placebo-Controlled Trial
Stoll, A. L., Severus, W. E., Freeman, M. P., Rueter, S., Zboyan, H. A., Diamond, E., Cress, K. K., & Marangell, L. B. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.5.407 · Cited by 814
Nemets, B., Stahl, Z., & Belmaker, R. H. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.3.477 · Cited by 627
Depletion of Omega-3 Fatty Acid Levels in Red Blood Cell Membranes of Depressive Patients
Peet, M., Murphy, B., Shay, J., & Horrobin, D. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00206-0 · Cited by 581
Self-citation
Cited by
Functional Roles of Fatty Acids and Their Effects on Human Health
Calder, P. C. (2015) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607115595980 · Cited by 1,160
Djuricic, I., & Calder, P. C. (2021) · Nutrients · doi:10.3390/nu13072421 · Cited by 1,015
Anderson, I., Ferrier, I., Baldwin, R., Cowen, P., Howard, L., Lewis, G., Matthews, K., McAllister-Williams, R., Peveler, R., Scott, J., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088441 · Cited by 908
Amminger, G. P., Schäfer, M. R., Papageorgiou, K., Klier, C. M., Cotton, S. M., Harrigan, S. M., Mackinnon, A., McGorry, P. D., & Berger, G. E. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.192 · Cited by 896
Cleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759
Lordan, S., Ross, R. P., & Stanton, C. (2011) · Marine Drugs · doi:10.3390/md9061056 · Cited by 748
Omega-3 Fatty Acids: Evidence Basis for Treatment and Future Research in Psychiatry
Freeman, M. P., Hibbeln, J. R., Wisner, K. L., Davis, J. M., Mischoulon, D., Peet, M., Keck, P. E., Marangell, L. B., Richardson, A. J., Lake, J., et al. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1217 · Cited by 709
Self-citationA Systemic Review of the Roles of n-3 Fatty Acids in Health and Disease
Riediger, N. D., Othman, R. A., Suh, M., & Moghadasian, M. H. (2009) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2008.12.022 · Cited by 695
Inflamed moods: A review of the interactions between inflammation and mood disorders
Rosenblat, J. D., Cha, D. S., Mansur, R. B., & McIntyre, R. S. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.01.013 · Cited by 609
Omega-3 fatty acids in major depressive disorder
Su, K.-P., Huang, S.-Y., Chiu, C.-C., & Shen, W. W. (2003) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(03)00032-4 · Cited by 596
Healthy intakes of n−3 and n–6 fatty acids: estimations considering worldwide diversity
Hibbeln, J. R., Nieminen, L. R., Blasbalg, T. L., Riggs, J. A., & Lands, W. E. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1483s · Cited by 539
A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression
Lin, P.-Y., Huang, S.-Y., & Su, K.-P. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.03.018 · Cited by 530
Kennedy, S. H., Lam, R. W., Parikh, S. V., Patten, S. B., & Ravindran, A. V. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.043 · Cited by 525
Stark, K. D., Van Elswyk, M. E., Higgins, M. R., Weatherford, C. A., & Salem, N. (2016) · Progress in Lipid Research · doi:10.1016/j.plipres.2016.05.001 · Cited by 519
Grosso, G., Pajak, A., Marventano, S., Castellano, S., Galvano, F., Bucolo, C., Drago, F., & Caraci, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096905 · Cited by 449
Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses
Sarris, J., Murphy, J., Mischoulon, D., Papakostas, G. I., Fava, M., Berk, M., & Ng, C. H. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.15091228 · Cited by 436
“study [31] and the threearm Jazayeri et al.”
Very long-chain n -3 fatty acids and human health: fact, fiction and the future
Calder, P. C. (2018) · Proceedings of the Nutrition Society · doi:10.1017/s0029665117003950 · Cited by 419
Meta-Analysis of the Effects of Eicosapentaenoic Acid (EPA) in Clinical Trials in Depression
Sublette, M. E., Ellis, S. P., Geant, A. L., & Mann, J. J. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m06634 · Cited by 417
Chiu, C.-C., Su, K.-P., Cheng, T.-C., Liu, H.-C., Chang, C.-J., Dewey, M. E., Stewart, R., & Huang, S.-Y. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.05.015 · Cited by 406
Dietary fats and membrane function: implications for metabolism and disease
Hulbert, A. J., Turner, N., Storlien, L. H., & Else, P. L. (2005) · Biological Reviews · doi:10.1017/s1464793104006578 · Cited by 406
Bergé, J.-P., & Barnathan, G. (2005) · Advances in Biochemical Engineering/Biotechnology · doi:10.1007/b135782 · Cited by 401
Omega-3 Fatty Acids and Mood Disorders
Parker, G., Gibson, N. A., Brotchie, H., Heruc, G., Rees, A.-M., & Hadzi-Pavlovic, D. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.6.969 · Cited by 384
Diet, Stress and Mental Health
Bremner, J., Moazzami, K., Wittbrodt, M., Nye, J., Lima, B., Gillespie, C., Rapaport, M., Pearce, B., Shah, A., & Vaccarino, V. (2020) · Nutrients · doi:10.3390/nu12082428 · Cited by 377
Martins, J. G. (2009) · Journal of the American College of Nutrition · doi:10.1080/07315724.2009.10719785 · Cited by 358
Appleton, K. M., Rogers, P. J., & Ness, A. R. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28313 · Cited by 353
Nutrition and Depression: Implications for Improving Mental Health Among Childbearing-Aged Women
Bodnar, L. M., & Wisner, K. L. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.009 · Cited by 351
Su, K.-P., Huang, S.-Y., Chiu, T.-H., Huang, K.-C., Huang, C.-L., Chang, H.-C., & Pariante, C. M. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0418 · Cited by 308
Intervention in Individuals at Ultra-High Risk for Psychosis: A Review and Future Directions
McGorry, P. D., Nelson, B., Amminger, G. P., Bechdolf, A., Francey, S. M., Berger, G., Riecher-Rössler, A., Klosterkötter, J., Ruhrmann, S., Schultze-Lutter, F., et al. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08r04472 · Cited by 305
Sinn, N., Milte, C. M., Street, S. J., Buckley, J. D., Coates, A. M., Petkov, J., & Howe, P. R. C. (2012) · British Journal of Nutrition · doi:10.1017/s0007114511004788 · Cited by 297
“Although high EPA or ethyl-EPA has been reportedly effective in some studies with depression((48,49)), we cannot rule out the effect of DHA.”
Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis
Bloch, M. H., & Hannestad, J. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.100 · Cited by 293
Hirayama, S., Hamazaki, T., & Terasawa, K. (2004) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601830 · Cited by 288
Alessandri, J.-M., Guesnet, P., Vancassel, S., Astorg, P., Denis, I., Langelier, B., Aïd, S., Poumès-Ballihaut, C., Champeil-Potokar, G., & Lavialle, M. (2004) · Reproduction Nutrition Development · doi:10.1051/rnd:2004063 · Cited by 283
Mirón, A. S., Garcı́a, M. C. C., Gómez, A. C., Camacho, F. G., Grima, E. M., & Chisti, Y. (2003) · Biochemical Engineering Journal · doi:10.1016/s1369-703x(03)00072-x · Cited by 279
Mocking, R. J. T., Harmsen, I., Assies, J., Koeter, M. W. J., Ruhé, H. G., & Schene, A. H. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.29 · Cited by 279
Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid?
Ross, B. M., Seguin, J., & Sieswerda, L. E. (2007) · Lipids in Health and Disease · doi:10.1186/1476-511x-6-21 · Cited by 275
Omega-3 fatty acids in ADHD and related neurodevelopmental disorders
Richardson, A. J. (2006) · International Review of Psychiatry · doi:10.1080/09540260600583031 · Cited by 267
Very long chain omega‐3 (n‐3) fatty acids and human health
Calder, P. C. (2014) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.201400025 · Cited by 265
Shelton, R. C., & Miller, A. H. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.004 · Cited by 261
McNamara, R. K., Hahn, C.-G., Jandacek, R., Rider, T., Tso, P., Stanford, K. E., & Richtand, N. M. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.08.026 · Cited by 260
Omega-3 Fatty Acids in the Treatment of Psychiatric Disorders
Peet, M., & Stokes, C. (2005) · Drugs · doi:10.2165/00003495-200565080-00002 · Cited by 258
Self-citationOmega-3 fatty acids from fish oils and cardiovascular disease
Holub, D. J., & Holub, B. J. (2004) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000041863.11248.8d · Cited by 258
Smaga, I., Niedzielska, E., Gawlik, M., Moniczewski, A., Krzek, J., Przegaliński, E., Pera, J., & Filip, M. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2014.12.015 · Cited by 252
“Several clinical trials supported the usefulness of omega-3 acids (polyunsaturated fatty acids) [34] or N-acetylcysteine (a mucolytic drug) [35–39] in depressed patients.”
BackgroundRogers, P. J., Appleton, K. M., Kessler, D., Peters, T. J., Gunnell, D., Hayward, R. C., Heatherley, S. V., Christian, L. M., McNaughton, S. A., & Ness, A. R. (2008) · British Journal of Nutrition · doi:10.1017/s0007114507801097 · Cited by 243
Keck, P. E., Mintz, J., McElroy, S. L., Freeman, M. P., Suppes, T., Frye, M. A., Altshuler, L. L., Kupka, R., Nolen, W. A., Leverich, G. S., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.056 · Cited by 234
Depressive symptoms, omega-6:omega-3 fatty acids, and inflammation in older adults.
Kiecolt-Glaser, J. K., Belury, M. A., Porter, K., Beversdorf, D. Q., Lemeshow, S., & Glaser, R. (2007) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3180313a45 · Cited by 212
da Silva, T. M., Munhoz, R. P., Alvarez, C., Naliwaiko, K., Kiss, Á., Andreatini, R., & Ferraz, A. C. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.03.008 · Cited by 205
Randomized dose‐ranging pilot trial of omega‐3 fatty acids for postpartum depression
Freeman, M. P., Hibbeln, J. R., Wisner, K. L., Brumbach, B. H., Watchman, M., & Gelenberg, A. J. (2006) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00660.x · Cited by 199
Johnson, M., Östlund, S., Fransson, G., Kadesjö, B., & Gillberg, C. (2009) · Journal of Attention Disorders · doi:10.1177/1087054708316261 · Cited by 198
Treatment-Resistant Depression and Mortality After Acute Coronary Syndrome
Carney, R. M., & Freedland, K. E. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08081239 · Cited by 163
Omega-3 Fatty Acid Augmentation of Citalopram Treatment for Patients With Major Depressive Disorder
Gertsik, L., Poland, R. E., Bresee, C., & Rapaport, M. H. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31823f3b5f · Cited by 162
DiNicolantonio, J. J., & O’Keefe, J. H. (2020) · Nutrients · doi:10.3390/nu12082333 · Cited by 147
The importance of n-6/n-3 fatty acids ratio in the major depressive disorder
Husted, K. S., & Bouzinova, E. V. (2016) · Medicina · doi:10.1016/j.medici.2016.05.003 · Cited by 142
Van Dael, P. (2021) · Nutrition Research and Practice · doi:10.4162/nrp.2021.15.2.137 · Cited by 138
Rees, A.-M., Austin, M.-P., & Parker, G. B. (2008) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670701827267 · Cited by 134
Sinn, N., Milte, C., & Howe, P. R. C. (2010) · Nutrients · doi:10.3390/nu2020128 · Cited by 115
Ravindran, A. V., Lam, R. W., Filteau, M. J., Lespérance, F., Kennedy, S. H., Parikh, S. V., & Patten, S. B. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.040 · Cited by 108
Peet, M. (2003) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.08.020 · Cited by 103
Self-citationBalmus, I. M., Ciobica, A., Antioch, I., Dobrin, R., & Timofte, D. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3975101 · Cited by 103
“Several data are adding up to the fundaments of this hypothesis which are emphasising on the intensified features for the association of antidepressant therapy with antioxidants such as omega3 acid [271] and N-acetylcysteine [272] in depressed persons and also anxiety SSRI resistant adolescents, all of these resulting…”
BackgroundFeeding melancholic microbes: MyNewGut recommendations on diet and mood
Dinan, T. G., Stanton, C., Long-Smith, C., Kennedy, P., Cryan, J. F., Cowan, C. S. M., Cenit, M. C., van der Kamp, J.-W., & Sanz, Y. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.11.010 · Cited by 95
Song, C., Phillips, A. G., Leonard, B. E., & Horrobin, D. F. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001462 · Cited by 91
Self-citationBrowne, J. C., Scott, K. M., & Silvers, K. M. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.10.009 · Cited by 86
Omega-3 fatty acids for depression in adults
Appleton, K. M., Voyias, P. D., Sallis, H. M., Dawson, S., Ness, A. R., Churchill, R., & Perry, R. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004692.pub5 · Cited by 84
Culpepper, L., Muskin, P. R., & Stahl, S. M. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.07.001 · Cited by 77
Acute EPA-induced learning and memory impairment in mice is prevented by DHA
Liu, J.-H., Wang, Q., You, Q.-L., Li, Z.-L., Hu, N.-Y., Wang, Y., Jin, Z.-L., Li, S.-J., Li, X.-W., Yang, J.-M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19255-1 · Cited by 77
Liu, J. J., Galfalvy, H. C., Cooper, T. B., Oquendo, M. A., Grunebaum, M. F., Mann, J. J., & Sublette, M. E. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12m07970 · Cited by 73
Cooper, R. E., Tye, C., Kuntsi, J., Vassos, E., & Asherson, P. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.09.053 · Cited by 73
N-3 Polyunsaturated Fatty Acids through the Lifespan: Implication for Psychopathology
Pusceddu, M. M., Kelly, P., Stanton, C., Cryan, J. F., & Dinan, T. G. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw078 · Cited by 70
An open trial of Omega-3 fatty acids for depression in pregnancy
Freeman, M. P., Hibbeln, J. R., Wisner, K. L., Watchman, M., & Gelenberg, A. J. (2006) · Acta Neuropsychiatrica · doi:10.1111/j.0924-2708.2006.00113.x · Cited by 49
BDNF as a Mediator of Antidepressant Response: Recent Advances and Lifestyle Interactions
Cubillos, S., Engmann, O., & Brancato, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214445 · Cited by 47
Zemdegs, J., Rainer, Q., Grossmann, C. P., Rousseau-Ralliard, D., Grynberg, A., Ribeiro, E., & Guiard, B. P. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00974 · Cited by 23
“, 2016), suggesting that supplementation with these fatty acids could be used as an “add-on” strategy to reduce treatment resistance, and potentiate treatment response (Peet and Horrobin, 2002; Jazayeri et al., 2008; Gertsik et al., 2012).”
BackgroundAcute and prophylactic effects of anticonvulsants in bipolar depression
Post, R. M., Speer, A. M., Obrocea, G. V., & Leverich, G. S. (2002) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(02)00047-6 · Cited by 20
Cheng, Y.-C., Chen, W.-Y., Lin, C., Lee, S.-H., Chiu, C.-C., & Kuo, P.-H. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.09.129 · Cited by 5
Metadata
- Authors
- Peet, M., & Horrobin, D. F.
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2002-10-01
- Volume
- 59
- Issue
- 10
- Pages
- 913
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2089036448
- Cited by
- 614
- References
- 33
- FWCI
- 31.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.